Yamamoto Shingo, Akiyama Kikuo, Yoshimoto Tetsuro, Kanokogi Mototsugu, Yabumoto Hidenori, Ihara Hideari, Ishikawa Eiji, Yoshioka Masaru, Kokura Koji, Shima Hiroki
The Department of Urology, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo, 663-8501, Japan.
J Infect Chemother. 2009 Apr;15(2):104-7. doi: 10.1007/s10156-009-0671-2. Epub 2009 Apr 25.
To assess the clinical efficacy of oral antibiotic administration for the treatment of lower urinary tract infection (UTI), 102 female patients were given gatifloxacin (200 mg once daily for 3 days). Five to nine days after treatment, drug safety and clinical efficacy were assessed by evaluation of urinalysis and symptoms. Further, the patients were asked to report by mail whether they had persistent or recurrent symptoms at 4-6 weeks after treatment. The overall clinical cure rate was 93.1% (95/102). Of 94 patients with susceptible pathogens and 8 with resistant pathogens, 89 (94.7%) and 6 (75.0%), respectively, were judged as clinically cured. Four to 6 weeks after treatment, 57 (55.9%) of the 102 patients reported their micturition status by mail, and 6 (10.5%) of them claimed that they had some symptoms. The outcomes of this study suggest that a therapeutic regimen such as administration of fluoroquinolones once daily for 3 days can be recommended for the treatment of uncomplicated cystitis.
为评估口服抗生素治疗下尿路感染(UTI)的临床疗效,对102例女性患者给予加替沙星(每日一次,每次200mg,共3天)。治疗后5至9天,通过尿液分析和症状评估药物安全性和临床疗效。此外,还要求患者在治疗后4至6周通过邮件报告是否有持续或复发症状。总体临床治愈率为93.1%(95/102)。在94例病原体敏感的患者和8例病原体耐药的患者中,分别有89例(94.7%)和6例(75.0%)被判定为临床治愈。治疗后4至6周,102例患者中有57例(55.9%)通过邮件报告了排尿情况,其中6例(10.5%)称仍有一些症状。本研究结果表明,对于单纯性膀胱炎的治疗,可推荐每日一次服用氟喹诺酮类药物3天的治疗方案。